01875 TOT BIOPHARM-B
- 1.680
- +0.100+6.33%
TOT BIOPHARM-B News
TOT BIOPHARM-B: NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED SHAREHOLDERS
TOT BIOPHARM-B: NOTIFICATION LETTER AND REQUEST FORM FOR REGISTERED SHAREHOLDERS
TOT BIOPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
TOT BIOPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
TOT BIOPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
TOT BIOPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
TOT BIOPHARM-B: FIRST LETTER AND REPLY FORM - ELECTION OF MEANS OF RECEIPT OF CORPORATE COMMUNICATIONS
TOT BIOPHARM-B: ELECTION OF MEANS OF RECEIPT OF CORPORATE COMMUNICATIONS
TOT BIOPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
TOT BIOPHARM-B: CERTAIN UNAUDITED FINANCIAL INFORMATION FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2023
TOT BIOPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
TOT BIOPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
TOT BIOPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023
TOT BIOPHARM-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
TOT BIOPHARM-B: CHANGE OF DIRECTORS AND CHANGE OF COMPOSITION OF BOARD COMMITTEES
TOT BIOPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
TOT BIOPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023
TOT BIOPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023
TOT BIOPHARM-B: FORM OF PROXY
TOT BIOPHARM-B: CERTAIN UNAUDITED FINANCIAL INFORMATION FOR THE THREE MONTHS ENDED 31 MARCH 2023
Analysis
Price Target
No Data
